Manila Bulletin
12 vaccine makers sign non-disclosure deals with PH, reports DOST
The Philippines is currently in negotiations with 25 COVID-19 vaccine developers from 10 different countries for potential vaccine supply.
Of these 25 developers, 12 have already signed confidentiality disclosure agreements with the Department of Science and Technology (DOST).
The signing of these agreements allows the developers to submit their data for evaluation by the Philippine vaccine expert panel and the health research ethics board.
The government has also approved clinical trials for vaccines developed by Jansen, Clover, and Sinovac, with specific target cities for each trial.
🤖
This story was generated by AI to help you understand the key points. For more detailed coverage, please see the news articles from trusted media outlets below.
News Sources
See how different news organizations are covering this story. Below are the original articles from various Philippine news sources that contributed to this summary.
The Philippines is negotiating with 25 COVID-19 vaccine developers from 10 countries for distribution, local manufacturing, and clinical trials.
Read more →
The Philippine government expects to finalize supply agreements for five COVID-19 vaccine brands by the end of February, according to Vaccine Czar Carlito Galvez Jr.
Read more →
Three COVID-19 vaccines, Clover, Janssen, and Sinovac, are expected to begin clinical trials in the Philippines this February or March.
+1
Read more →
The Philippines is set to receive at least 5.6 million doses of COVID-19 vaccines within the first quarter of 2021, with deliveries expected to start in February.
+2
Read more →
The Philippines is set to receive at least 56 million doses of COVID-19 vaccines from American companies by May, according to Philippine Ambassador to the US Jose Manuel Romualdez.
Read more →